AIDS Healthcare Foundation (AHF) welcomes the release of reports exposing the drug industry’s disinformation campaign attacking the 340B Drug Pricing Program. Ryan White Clinics for 340B Access last week published a rebuttal against the plethora of so-called ‘studies’ whose authors have financial ties to the drug industry.

Ryan White Clinics for 340B Access (https://rwc340b.org/), a national organization of non-profit safety net clinics who serve people living with HIV under the U.S. Ryan White HIV/AIDS Program, released these reports that respond to the drug industry’s disinformation campaign https://rwc340b.org/wp-content/uploads/2022/09/RWC-340B-Rebuttal-to-Drug-Industry-Attacks-on-340B.pdf and the financial ties of the authors of the so-called studies to the drug industry Information on Financial Ties between authors of anti-340B articles and PhRMA (D1014854-5).DOCX (rwc340b.org).

“The 340B program is essential to the U.S. healthcare safety net. It costs taxpayers nothing. It benefits safety-net providers and the people they serve. The drug industry wants to strangle it. Congress should leave it alone because it’s working as intended,” said John Hassell, AHF’s national director of advocacy. “We join Ryan White Clinics for 340B Access in warning federal and state lawmakers of the dangerous lies the industry is promoting in order to increase their profits.”

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220927006145/en/

AHF joins Ryan White Clinics for 340B Access in warning federal and state lawmakers of the dangerous lies the drug industry is promoting in order to increase their obscene profits by strangling the lifesaving 340B drug pricing program.